TY - JOUR AU - Go, A. S. AU - Mozaffarian, D. AU - Roger, V. L. AU - Benjamin, E. J. AU - Berry, J. D. AU - Blaha, M. J. AU - Dai, S. AU - Ford, E. S. AU - Fox, C. S. AU - Franco, S. PY - 2014 DA - 2014// TI - Heart disease and stroke statistics--2014 update: a report from the American Heart Association JO - Circulation VL - 129 UR - https://doi.org/10.1161/01.cir.0000441139.02102.80 DO - 10.1161/01.cir.0000441139.02102.80 ID - Go2014 ER - TY - JOUR AU - Goff, D. C. AU - Lloyd-Jones, D. M. AU - Bennett, G. AU - Coady, S. AU - D’Agostino, R. B. AU - Gibbons, R. AU - Greenland, P. AU - Lackland, D. T. AU - Levy, D. AU - O’Donnell, C. J. PY - 2014 DA - 2014// TI - 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines JO - J Am Coll Cardiol VL - 63 UR - https://doi.org/10.1016/j.jacc.2013.11.005 DO - 10.1016/j.jacc.2013.11.005 ID - Goff2014 ER - TY - JOUR PY - 2002 DA - 2002// TI - Treatment of High Blood Cholesterol in A: Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report JO - Circulation VL - 106 ID - ref3 ER - TY - JOUR AU - Stone, N. J. AU - Robinson, J. G. AU - Lichtenstein, A. H. AU - Bairey Merz, C. N. AU - Blum, C. B. AU - Eckel, R. H. AU - Goldberg, A. C. AU - Gordon, D. AU - Levy, D. AU - Lloyd-Jones, D. M. PY - 2014 DA - 2014// TI - 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines JO - J Am Coll Cardiol VL - 25 Pt B UR - https://doi.org/10.1016/j.jacc.2013.11.002 DO - 10.1016/j.jacc.2013.11.002 ID - Stone2014 ER - TY - JOUR AU - Grabowski, D. C. AU - Lakdawalla, D. N. AU - Goldman, D. P. AU - Eber, M. AU - Liu, L. Z. AU - Abdelgawad, T. AU - Kuznik, A. AU - Chernew, M. E. AU - Philipson, T. PY - 2012 DA - 2012// TI - The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment JO - Health Aff (Millwood) VL - 31 UR - https://doi.org/10.1377/hlthaff.2011.1120 DO - 10.1377/hlthaff.2011.1120 ID - Grabowski2012 ER - TY - JOUR AU - Krauss, R. M. PY - 2010 DA - 2010// TI - Lipoprotein subfractions and cardiovascular disease risk JO - Curr Opin Lipidol VL - 21 UR - https://doi.org/10.1097/MOL.0b013e32833b7756 DO - 10.1097/MOL.0b013e32833b7756 ID - Krauss2010 ER - TY - JOUR AU - Krauss, R. M. PY - 2014 DA - 2014// TI - All low-density lipoprotein particles are not created equal JO - Arterioscler Thromb Vasc Biol VL - 34 UR - https://doi.org/10.1161/ATVBAHA.114.303458 DO - 10.1161/ATVBAHA.114.303458 ID - Krauss2014 ER - TY - JOUR AU - Melander, O. AU - Shiffman, D. AU - Caulfield, M. P. AU - Louie, J. Z. AU - Rowland, C. M. AU - Devlin, J. J. AU - Krauss, R. M. PY - 2015 DA - 2015// TI - Low-density lipoprotein particle number is associated with cardiovascular events among those Not classified into statin benefit groups JO - J Am Coll Cardiol VL - 65 UR - https://doi.org/10.1016/j.jacc.2015.02.077 DO - 10.1016/j.jacc.2015.02.077 ID - Melander2015 ER - TY - JOUR AU - Kooter, A. J. AU - Kostense, P. J. AU - Groenewold, J. AU - Thijs, A. AU - Sattar, N. AU - Smulders, Y. M. PY - 2011 DA - 2011// TI - Integrating information from novel risk factors with calculated risks: the critical impact of risk factor prevalence JO - Circulation VL - 124 UR - https://doi.org/10.1161/CIRCULATIONAHA.111.035725 DO - 10.1161/CIRCULATIONAHA.111.035725 ID - Kooter2011 ER - TY - CHAP AU - Collett, D. PY - 2003 DA - 2003// BT - Modeling survival data in medical research ID - Collett2003 ER - TY - JOUR AU - Ridker, P. M. AU - Danielson, E. AU - Fonseca, F. A. AU - Genest, J. AU - Gotto, A. M. AU - Kastelein, J. J. AU - Koenig, W. AU - Libby, P. AU - Lorenzatti, A. J. AU - MacFadyen, J. G. PY - 2008 DA - 2008// TI - Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0807646 DO - 10.1056/NEJMoa0807646 ID - Ridker2008 ER - TY - JOUR AU - Mohr, F. W. AU - Morice, M. C. AU - Kappetein, A. P. AU - Feldman, T. E. AU - Stahle, E. AU - Colombo, A. AU - Mack, M. J. AU - Holmes, D. R. AU - Morel, M. A. AU - Dyck, N. PY - 2013 DA - 2013// TI - Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(13)60141-5 DO - 10.1016/S0140-6736(13)60141-5 ID - Mohr2013 ER - TY - JOUR AU - Cannon, C. P. AU - Blazing, M. A. AU - Giugliano, R. P. AU - McCagg, A. AU - White, J. A. AU - Theroux, P. AU - Darius, H. AU - Lewis, B. S. AU - Ophuis, T. O. AU - Jukema, J. W. PY - 2015 DA - 2015// TI - Ezetimibe added to statin therapy after acute coronary syndromes JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1410489 DO - 10.1056/NEJMoa1410489 ID - Cannon2015 ER - TY - JOUR AU - Greisenegger, S. AU - Segal, H. C. AU - Burgess, A. I. AU - Poole, D. L. AU - Mehta, Z. AU - Rothwell, P. M. PY - 2015 DA - 2015// TI - Biomarkers and mortality after transient ischemic attack and minor ischemic stroke: population-based study JO - Stroke a j cereb circulation VL - 46 UR - https://doi.org/10.1161/STROKEAHA.114.007624 DO - 10.1161/STROKEAHA.114.007624 ID - Greisenegger2015 ER - TY - JOUR AU - Law, M. R. AU - Watt, H. C. AU - Wald, N. J. PY - 2002 DA - 2002// TI - The underlying risk of death after myocardial infarction in the absence of treatment JO - Arch Intern Med VL - 162 UR - https://doi.org/10.1001/archinte.162.21.2405 DO - 10.1001/archinte.162.21.2405 ID - Law2002 ER - TY - JOUR AU - Wannamethee, S. G. AU - Shaper, A. G. AU - Whincup, P. H. AU - Lennon, L. AU - Sattar, N. PY - 2011 DA - 2011// TI - Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors JO - Arch Intern Med VL - 171 UR - https://doi.org/10.1001/archinternmed.2011.2 DO - 10.1001/archinternmed.2011.2 ID - Wannamethee2011 ER - TY - JOUR AU - Bulugahapitiya, U. AU - Siyambalapitiya, S. AU - Sithole, J. AU - Idris, I. PY - 2009 DA - 2009// TI - Is diabetes a coronary risk equivalent? systematic review and meta-analysis JO - Diabet Med VL - 26 UR - https://doi.org/10.1111/j.1464-5491.2008.02640.x DO - 10.1111/j.1464-5491.2008.02640.x ID - Bulugahapitiya2009 ER - TY - JOUR AU - Idris, I. PY - 2011 DA - 2011// TI - Diabetes and cardiovascular risk equivalency: do age at diagnosis and disease duration affect risk stratification?: comment on “impact of diabetes on cardiovascular disease risk and all-cause mortality in older men” JO - Arch Intern Med VL - 171 UR - https://doi.org/10.1001/archinternmed.2010.524 DO - 10.1001/archinternmed.2010.524 ID - Idris2011 ER - TY - JOUR AU - Brun, E. AU - Nelson, R. G. AU - Bennett, P. H. AU - Imperatore, G. AU - Zoppini, G. AU - Verlato, G. AU - Muggeo, M. AU - Verona Diabetes, S. PY - 2000 DA - 2000// TI - Diabetes duration and cause-specific mortality in the Verona diabetes study JO - Diabetes Care VL - 23 UR - https://doi.org/10.2337/diacare.23.8.1119 DO - 10.2337/diacare.23.8.1119 ID - Brun2000 ER - TY - STD TI - Bureau of Labor Statistics. Consumer Price Index. Washington: US Department of Labor; 2014. Accessed 1 Apr 2015. ID - ref20 ER - TY - JOUR AU - Pandya, A. AU - Sy, S. AU - Cho, S. AU - Weinstein, M. C. AU - Gaziano, T. A. PY - 2015 DA - 2015// TI - Cost-effectiveness of 10-year risk thresholds for initiation of statin therapy for primary prevention of cardiovascular disease JO - JAMA VL - 314 UR - https://doi.org/10.1001/jama.2015.6822 DO - 10.1001/jama.2015.6822 ID - Pandya2015 ER - TY - JOUR AU - Sullivan, P. W. AU - Ghushchyan, V. PY - 2006 DA - 2006// TI - Preference-based EQ-5D index scores for chronic conditions in the United States JO - Med Decis Making VL - 26 UR - https://doi.org/10.1177/0272989X06290495 DO - 10.1177/0272989X06290495 ID - Sullivan2006 ER - TY - JOUR AU - Weinstein, M. C. AU - Siegel, J. E. AU - Gold, M. R. AU - Kamlet, M. S. AU - Russell, L. B. PY - 1996 DA - 1996// TI - Recommendations of the panel on cost-effectiveness in health and medicine JO - JAMA VL - 276 UR - https://doi.org/10.1001/jama.1996.03540150055031 DO - 10.1001/jama.1996.03540150055031 ID - Weinstein1996 ER - TY - JOUR AU - Husereau, D. AU - Drummond, M. AU - Petrou, S. AU - Carswell, C. AU - Moher, D. AU - Greenberg, D. AU - Augustovski, F. AU - Briggs, A. H. AU - Mauskopf, J. AU - Loder, E. PY - 2013 DA - 2013// TI - Consolidated health economic evaluation reporting standards (CHEERS) statement JO - Pharmacoeconomics VL - 31 UR - https://doi.org/10.1007/s40273-013-0032-y DO - 10.1007/s40273-013-0032-y ID - Husereau2013 ER - TY - JOUR AU - Galper, B. Z. AU - Wang, Y. C. AU - Einstein, A. J. PY - 2015 DA - 2015// TI - Strategies for primary prevention of coronary heart disease based on risk stratification by the ACC/AHA lipid guidelines, ATP III guidelines, coronary calcium scoring, and C-reactive protein, and a global treat-All strategy: a comparative--effectiveness modeling study JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0138092 DO - 10.1371/journal.pone.0138092 ID - Galper2015 ER - TY - JOUR AU - Deano, R. C. AU - Pandya, A. AU - Jones, E. C. AU - Borden, W. B. PY - 2014 DA - 2014// TI - A look at statin cost-effectiveness in view of the 2013 ACC/AHA cholesterol management guidelines JO - Curr Atheroscler Rep VL - 16 UR - https://doi.org/10.1007/s11883-014-0438-9 DO - 10.1007/s11883-014-0438-9 ID - Deano2014 ER - TY - JOUR AU - Pignone, M. AU - Earnshaw, S. AU - Tice, J. A. AU - Pletcher, M. J. PY - 2006 DA - 2006// TI - Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis JO - Ann Intern Med VL - 144 UR - https://doi.org/10.7326/0003-4819-144-5-200603070-00007 DO - 10.7326/0003-4819-144-5-200603070-00007 ID - Pignone2006 ER - TY - JOUR AU - Pletcher, M. J. AU - Lazar, L. AU - Bibbins-Domingo, K. AU - Moran, A. AU - Rodondi, N. AU - Coxson, P. AU - Lightwood, J. AU - Williams, L. AU - Goldman, L. PY - 2009 DA - 2009// TI - Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering JO - Ann Intern Med VL - 150 UR - https://doi.org/10.7326/0003-4819-150-4-200902170-00005 DO - 10.7326/0003-4819-150-4-200902170-00005 ID - Pletcher2009 ER - TY - JOUR AU - Lazar, L. D. AU - Pletcher, M. J. AU - Coxson, P. G. AU - Bibbins-Domingo, K. AU - Goldman, L. PY - 2011 DA - 2011// TI - Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era JO - Circulation VL - 124 UR - https://doi.org/10.1161/CIRCULATIONAHA.110.986349 DO - 10.1161/CIRCULATIONAHA.110.986349 ID - Lazar2011 ER - TY - JOUR AU - Hlatky, M. A. PY - 2014 DA - 2014// TI - To test or not to test, that is the question JO - Circ Cardiovasc Qual Outcomes VL - 7 UR - https://doi.org/10.1161/CIRCOUTCOMES.114.000886 DO - 10.1161/CIRCOUTCOMES.114.000886 ID - Hlatky2014 ER - TY - JOUR AU - Pletcher, M. J. AU - Pignone, M. AU - Earnshaw, S. AU - McDade, C. AU - Phillips, K. A. AU - Auer, R. AU - Zablotska, L. AU - Greenland, P. PY - 2014 DA - 2014// TI - Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis JO - Circ Cardiovasc Qual Outcomes VL - 7 UR - https://doi.org/10.1161/CIRCOUTCOMES.113.000799 DO - 10.1161/CIRCOUTCOMES.113.000799 ID - Pletcher2014 ER - TY - JOUR AU - Lee, K. K. AU - Cipriano, L. E. AU - Owens, D. K. AU - Go, A. S. AU - Hlatky, M. A. PY - 2010 DA - 2010// TI - Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy JO - Circulation VL - 122 UR - https://doi.org/10.1161/CIRCULATIONAHA.110.947960 DO - 10.1161/CIRCULATIONAHA.110.947960 ID - Lee2010 ER - TY - JOUR AU - Hutchins, R. AU - Viera, A. J. AU - Sheridan, S. L. AU - Pignone, M. P. PY - 2015 DA - 2015// TI - Quantifying the utility of taking pills for cardiovascular prevention JO - Circ Cardiovasc Qual Outcomes VL - 8 UR - https://doi.org/10.1161/CIRCOUTCOMES.114.001240 DO - 10.1161/CIRCOUTCOMES.114.001240 ID - Hutchins2015 ER - TY - JOUR AU - Iannaccone, M. AU - Quadri, G. AU - Taha, S. AU - D’Ascenzo, F. AU - Montefusco, A. AU - Omede, P. AU - Jang, I. K. AU - Niccoli, G. AU - Souteyrand, G. AU - Yundai, C. AU - Toutouzas, K. AU - Benedetto, S. AU - Barbero, U. AU - Annone, U. AU - Lonni, E. AU - Imori, Y. AU - Biondi-Zoccai, G. AU - Templin, C. AU - Moretti, C. AU - Luscher, T. F. AU - Gaita, F. PY - 2016 DA - 2016// TI - Prevalence and predictors of culprit plaque rupture at OCT in patients with coronary artery disease: a meta-analysis JO - Eur Heart J Cardiovasc Imaging VL - 17 UR - https://doi.org/10.1093/ehjci/jev283 DO - 10.1093/ehjci/jev283 ID - Iannaccone2016 ER - TY - JOUR AU - Ohsfeldt, R. L. AU - Gandhi, S. K. AU - Smolen, L. J. AU - Jensen, M. M. AU - Fox, K. M. AU - Gold, A. AU - Hsia, J. PY - 2010 DA - 2010// TI - Cost effectiveness of rosuvastatin in patients at risk of cardiovascular disease based on findings from the JUPITER trial JO - J Med Econ VL - 13 UR - https://doi.org/10.3111/13696998.2010.499758 DO - 10.3111/13696998.2010.499758 ID - Ohsfeldt2010 ER - TY - JOUR AU - Choudhry, N. K. AU - Patrick, A. R. AU - Glynn, R. J. AU - Avorn, J. PY - 2011 DA - 2011// TI - The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels JO - J Am Coll Cardiol VL - 57 UR - https://doi.org/10.1016/j.jacc.2010.07.059 DO - 10.1016/j.jacc.2010.07.059 ID - Choudhry2011 ER - TY - STD TI - Clinical Lab Fee Schedule, 2010 (10CLAB). www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/Clinical-Laboratory-Fee-Schedule-Files.html. Accessed 15 Apr 2015.  UR - http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/Clinical-Laboratory-Fee-Schedule-Files.html ID - ref37 ER - TY - JOUR AU - O’Sullivan, A. K. AU - Rubin, J. AU - Nyambose, J. AU - Kuznik, A. AU - Cohen, D. J. AU - Thompson, D. PY - 2011 DA - 2011// TI - Cost estimation of cardiovascular disease events in the US JO - Pharmacoeconomics VL - 29 UR - https://doi.org/10.2165/11584620-000000000-00000 DO - 10.2165/11584620-000000000-00000 ID - O’Sullivan2011 ER - TY - STD TI - www.healthwarehouse.com. Accessed 1 Apr 2015. UR - http://www.healthwarehouse.com ID - ref39 ER - TY - STD TI - Trends in Use and Expenditures for Diabetes among Adults 18 and Older, U.S. Civilian Noninstitutionalized Population, 1996 and 2007. Statistical Brief #304. [http://meps.ahrq.gov/mepsweb/data_files/publications/st304/stat304.shtml]. Accessed 15 Apr 2015. UR - http://meps.ahrq.gov/mepsweb/data_files/publications/st304/stat304.shtml ID - ref40 ER - TY - JOUR AU - Kashani, A. AU - Phillips, C. O. AU - Foody, J. M. AU - Wang, Y. AU - Mangalmurti, S. AU - Ko, D. T. AU - Krumholz, H. M. PY - 2006 DA - 2006// TI - Risks associated with statin therapy: a systematic overview of randomized clinical trials JO - Circulation VL - 114 UR - https://doi.org/10.1161/CIRCULATIONAHA.106.624890 DO - 10.1161/CIRCULATIONAHA.106.624890 ID - Kashani2006 ER -